Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16

被引:47
作者
Cabrera-Rode, E
Sarmiento, L
Tiberti, C
Molina, G
Barrios, J
Hernández, D
Díaz-Horta, O
Di Mario, U
机构
[1] Natl Inst Endocrinol, Dept Innumol Diabet, Havana, Cuba
[2] Inst Trop Med Pedro Kouri, Havana, Cuba
[3] Univ Roma La Sapienza, Med Clin 2, Rome, Italy
关键词
islet cell antibodies; insulin autoantibodies; glutamic acid decarboxylase antibodies; tyrosine phosphatase antibodies; virus; enterovirus; echovirus; neutralizing antibodies; Type; 1; diabetes;
D O I
10.1007/s00125-003-1179-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. To determine whether the emergent infection by echovirus 16 that occurred in Cuba during the year 2000 was related to the presence of Type 1 diabetes associated autoantibodies. Methods. The presence of ICA, IAA, GADA, IA2 antibodies and neutralizing antibodies (NtAb) to echovirus 16 were determined in sera from 38 infected children and adolescents and 80 control subjects, matched in sex, age, local residence and time of sample collection. Results. The occurrence of a large-scale echovirus 16 epidemic was associated with the appearance of humoral autoimmune markers of Type 1 diabetes, especially for ICA, IAA and GADA. In the convalescent stage, ICA, IAA and GADA seroconversion was shown in 92.1%, 44.7% and 28.9% of echovirus 16 infected subjects. None of the 80 uninfected subjects had ICA or IAA, while one was GADA positive. ICA, IAA and GADA frequency was higher in the convalescent than in the acute stage (p<0.0005). A strong positive correlation was found between the NtAb to echovirus 16 and ICA titres in both acute and convalescent stage (r=0.91; p<0.0001, r=0.55; p=0.0003 respectively). Conclusion/interpretation. This work provides evidence of an association between echovirus 16 infection and the presence of Type 1 diabetes related antibodies (ICA, IAA and GADA). Our data show that the echovirus 16 infection might be capable of inducing a process of autoimmune beta-cell damage and support the hypothesis that enterovirus infections are important risk factors for the development of Type 1 diabetes.
引用
收藏
页码:1348 / 1353
页数:6
相关论文
共 50 条
[41]   Mapping T Cell Responses to Native and Neo-Islet Antigen Epitopes in at Risk and Type 1 Diabetes Subjects [J].
Arif, Sefina ;
Pujol-Autonell, Irma ;
Kamra, Yogesh ;
Williams, Evangelia ;
Yusuf, Norkhairin ;
Domingo-Vila, Clara ;
Shahrabi, Yasaman ;
Pollock, Emily ;
Khatri, Leena ;
Peakman, Mark ;
Tree, Timothy ;
Lorenc, Anna .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[42]   Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children [J].
Larsson, Helena Elding ;
Lynch, Kristian F. ;
Lonnrot, Maria ;
Haller, Michael J. ;
Lernmark, Ake ;
Hagopian, William A. ;
She, Jin-Xiong ;
Simell, Olli ;
Toppari, Jorma ;
Ziegler, Anette-G. ;
Akolkar, Beena ;
Krischer, Jeffrey P. ;
Rewers, Marian J. ;
Hyoty, Heikki .
DIABETOLOGIA, 2018, 61 (01) :193-202
[43]   Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance [J].
Redondo, Maria J. ;
Sosenko, Jay ;
Libman, Ingrid ;
McVean, Jennifer J. F. ;
Tosur, Mustafa ;
Atkinson, Mark A. ;
Becker, Dorothy ;
Geyer, Susan .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (05)
[44]   Advances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count [J].
So, Michelle ;
Speake, Cate ;
Steck, Andrea K. ;
Lundgren, Markus ;
Colman, Peter G. ;
Palmer, Jerry P. ;
Herold, Kevan C. ;
Greenbaum, Carla J. .
ENDOCRINE REVIEWS, 2021, 42 (05) :584-604
[45]   Circulating metabolites in progression to islet autoimmunity and type 1 diabetes [J].
Lamichhane, Santosh ;
Kemppainen, Esko ;
Trost, Kajetan ;
Siljander, Heli ;
Hyoety, Heikki ;
Ilonen, Jorma ;
Toppari, Jorma ;
Veijola, Riitta ;
Hyoetylaeinen, Tuulia ;
Knip, Mikael ;
Oresic, Matej .
DIABETOLOGIA, 2019, 62 (12) :2287-2297
[46]   Islet transplantation for Type 1 diabetes: where are we now? [J].
Ahearn, Aaron J. ;
Parekh, Justin R. ;
Posselt, Andrew M. .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (01) :59-68
[47]   Clinical Benefit of Islet Xenotransplantation for the Treatment of Type 1 Diabetes [J].
Matsumoto, Shinichi ;
Abalovich, Adrian ;
Wechsler, Carlos ;
Wynyard, Shaun ;
Elliott, Robert B. .
EBIOMEDICINE, 2016, 12 :255-262
[48]   RELATIONSHIP BETWEEN URINARY NEOPTERIN EXCRETION AND ISLET CELL ANTIBODIES IN TYPE-1 (INSULIN-DEPENDENT) DIABETES [J].
MANNA, R ;
SALVATORE, M ;
DILEO, MAS ;
SCUDERI, F ;
GRECO, AV ;
GHIRLANDA, G ;
GAMBASSI, G .
DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 1991, 17 (01) :33-36
[49]   Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the Eseverity of islet amyloidosis [J].
Esapa, C ;
Moffitt, JH ;
Novials, A ;
McNamara, CM ;
Levy, JC ;
Laakso, M ;
Gomis, R ;
Clark, A .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2005, 1740 (01) :74-78
[50]   Antibodies to post-translationally modified insulin in type 1 diabetes [J].
Strollo, Rocky ;
Vinci, Chiara ;
Arshad, Mayda H. ;
Perrett, David ;
Tiberti, Claudio ;
Chiarelli, Francesco ;
Napoli, Nicola ;
Pozzilli, Paolo ;
Nissim, Ahuva .
DIABETOLOGIA, 2015, 58 (12) :2851-2860